Stock Information
Roivant Sciences Ltd (ROIV)
Ticker Symbol: ROIV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $28,553.43 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.39
Revenue (TTM): $0.01 M
Dividend Yield: N/A
ROE: -6.12%
Latest News
-
Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's Why
Fri, Nov 20, 2026 4:00 PM
-
Wall Street Analysts Think Montes Archimedes Acquisition (ROIV) Could Surge 29.62%: Read This Before Placing a Bet
Fri, Nov 20, 2026 1:55 PM
-
Keith Manchester Sells $54M Of Roivant Sciences Stock After Sharp Run-Up
Thu, Nov 19, 2026 10:05 AM
-
David Einhorn Bets on Aluminum in Q3: Here Are His New Stock Picks, Fund Changes
Tue, Nov 17, 2026 12:36 PM
-
Roivant Sciences Ltd. (ROIV) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Tue, Nov 17, 2026 10:42 AM
-
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $48
Mon, Nov 16, 2026 10:14 AM
Key Financials
Financial data not available